Nektar Therapeutics Stock Price Prediction
| NKTR Stock | USD 1.21 0.05 3.97% |
Oversold Vs Overbought
45
Oversold | Overbought |
EPS Estimate Next Quarter (0.20) | EPS Estimate Current Year (0.81) | EPS Estimate Next Year (0.69) | Wall Street Target Price 1.6 | EPS Estimate Current Quarter (0.19) |
Using Nektar Therapeutics hype-based prediction, you can estimate the value of Nektar Therapeutics from the perspective of Nektar Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Nektar Therapeutics using Nektar Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Nektar using crowd psychology based on the activity and movement of Nektar Therapeutics' stock price.
Nektar Therapeutics Short Interest
An investor who is long Nektar Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Nektar Therapeutics and may potentially protect profits, hedge Nektar Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 0.8207 | Short Percent 0.0185 | Short Ratio 1.41 | Shares Short Prior Month 3.5 M | 50 Day MA 1.4654 |
Nektar Therapeutics Hype to Price Pattern
Investor biases related to Nektar Therapeutics' public news can be used to forecast risks associated with an investment in Nektar. The trend in average sentiment can be used to explain how an investor holding Nektar can time the market purely based on public headlines and social activities around Nektar Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Nektar Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Nektar Therapeutics.
Nektar Therapeutics Implied Volatility | 147.31 |
Nektar Therapeutics' implied volatility exposes the market's sentiment of Nektar Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nektar Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nektar Therapeutics stock will not fluctuate a lot when Nektar Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Nektar Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Nektar because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nektar Therapeutics after-hype prediction price | USD 1.17 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Nektar |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nektar Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nektar Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Nektar Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nektar Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nektar Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nektar Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Nektar Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nektar Therapeutics' historical news coverage. Nektar Therapeutics' after-hype downside and upside margins for the prediction period are 0.06 and 8.06, respectively. We have considered Nektar Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nektar Therapeutics is extremely dangerous at this time. Analysis and calculation of next after-hype price of Nektar Therapeutics is based on 3 months time horizon.
Nektar Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Nektar Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nektar Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nektar Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.77 | 6.89 | 0.04 | 0.10 | 9 Events / Month | 6 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.21 | 1.17 | 3.31 |
|
Nektar Therapeutics Hype Timeline
Nektar Therapeutics is now traded for 1.21. The entity has historical hype elasticity of -0.04, and average elasticity to hype of competition of -0.1. Nektar is anticipated to decline in value after the next headline, with the price expected to drop to 1.17. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -3.31%, whereas the daily expected return is now at 0.77%. The volatility of related hype on Nektar Therapeutics is about 5167.5%, with the expected price after the next announcement by competition of 1.11. About 62.0% of the company shares are owned by institutional investors. The book value of Nektar Therapeutics was now reported as 0.69. The company recorded a loss per share of 0.91. Nektar Therapeutics had not issued any dividends in recent years. The entity had 2:1 split on the 23rd of August 2000. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Nektar Therapeutics Basic Forecasting Models to cross-verify your projections.Nektar Therapeutics Related Hype Analysis
Having access to credible news sources related to Nektar Therapeutics' direct competition is more important than ever and may enhance your ability to predict Nektar Therapeutics' future price movements. Getting to know how Nektar Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nektar Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALDX | Aldeyra | 0.08 | 10 per month | 3.53 | 0.03 | 8.56 | (6.97) | 24.10 | |
| TVTX | Travere Therapeutics | 0.08 | 8 per month | 0.00 | (0.06) | 5.70 | (7.61) | 17.92 | |
| CNTB | Connect Biopharma Holdings | (0.08) | 7 per month | 6.29 | 0.11 | 19.51 | (10.42) | 42.32 | |
| ABOS | Acumen Pharmaceuticals | (0.09) | 8 per month | 0.00 | (0.17) | 5.58 | (6.15) | 18.27 | |
| NUVB | Nuvation Bio | 0.04 | 7 per month | 4.51 | 0.06 | 10.07 | (8.31) | 50.11 | |
| ELDN | Eledon Pharmaceuticals | (0.03) | 8 per month | 4.48 | 0.16 | 11.24 | (7.38) | 35.55 | |
| OPT | Opthea | (0.02) | 8 per month | 0.00 | (0.11) | 5.83 | (6.32) | 21.84 | |
| CNTA | Centessa Pharmaceuticals PLC | 0.04 | 8 per month | 0.00 | (0.05) | 6.00 | (6.00) | 17.90 | |
| NUVL | Nuvalent | (1.22) | 12 per month | 0.00 | (0.02) | 4.82 | (4.39) | 13.91 |
Nektar Therapeutics Additional Predictive Modules
Most predictive techniques to examine Nektar price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nektar using various technical indicators. When you analyze Nektar charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nektar Therapeutics Predictive Indicators
The successful prediction of Nektar Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nektar Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nektar Therapeutics based on analysis of Nektar Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nektar Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nektar Therapeutics's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 15.44 | 9.31 | 4.75 | 7.16 | Receivables Turnover | 4.53 | 15.39 | 40.02 | 42.02 |
Story Coverage note for Nektar Therapeutics
The number of cover stories for Nektar Therapeutics depends on current market conditions and Nektar Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nektar Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nektar Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Nektar Therapeutics Short Properties
Nektar Therapeutics' future price predictability will typically decrease when Nektar Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nektar Therapeutics often depends not only on the future outlook of the potential Nektar Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nektar Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 190 M | |
| Cash And Short Term Investments | 303.6 M |
Additional Tools for Nektar Stock Analysis
When running Nektar Therapeutics' price analysis, check to measure Nektar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nektar Therapeutics is operating at the current time. Most of Nektar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nektar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nektar Therapeutics' price. Additionally, you may evaluate how the addition of Nektar Therapeutics to your portfolios can decrease your overall portfolio volatility.